LYRA (Lyra Therapeutics, Inc.) Short-Term Debt to Capital
This visual market valuation helps analyze the resilience of Lyra Therapeutics, Inc. (LYRA), whose competitive moat is based on nasal implant patents and lobbyist support under strict FDA oversight. The indicator stands at 0.00. Lyra Therapeutics, Inc. (LYRA) is implementing eco-friendly synthesis and zero-waste chemical disposal. The business relies on an open niche for non-surgical rhinosinusitis treatment, ensuring stable demand from physicians.
Analytical breakdowns for Lyra Therapeutics, Inc.
- stock quotes and analyst forecast:
- business market valuation indicators:
- book capitalization information:
- company liabilities and liquidity data:
Total Debt to Capital Lyra Therapeutics, Inc.|LYRA - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Lyra Therapeutics|LYRA - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Lyra Therapeutics Inc.|LYRA - Long-Term Debt|Company Current Liabilities Lyra Therapeutics|Quick Ratio lyratherapeutics.com
- company profitability and valuation multiples indicators:
Fundamental valuation:LYRA Lyra Therapeutics, Inc
This ratio determines the share of short-term liabilities within the equity structure, reflecting the issuer's level of dependence on operational debt financing. By analyzing the trend of short-term debt to equity, an investor can assess the financial stability of Lyra Therapeutics, Inc. (LYRA) while scaling its drug delivery platform and preparing for the mass market launch of ENT products.
Competitors of Lyra Therapeutics, Inc. (LYRA)
Short-Term Debt to Capital HLN|KVUE (Kenvue Health) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital VRNA (Verona Pharma plc)|Short-Term Debt to Capital jyongbio.com MENS|LGND - Short-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital AMRX (Amneal Pharmaceuticals, Inc.)|Perrigo Company (PRGO) - Short-Term Debt to Equity|Short-Term Debt to Equity Ratio Alvotech Biopharmaceuticals|LQDA (Liquidia Corporation) - Short-Term Debt to Capital|Short-Term Debt to Capital glpg.com|Short-Term Debt to Equity Ratio ANIP (ANI Pharmaceuticals, Inc.)|MNKD (MannKind Corp) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity Amphastar AMPH|Pacira Corp (PCRX) - Current Liabilities to Capital|SPRY: Short-Term Debt to Equity Ratio|theravance.com - Short-Term Loans to Capital Ratio|AQST: Short-Term Debt to Capital|scPharmaceuticals - Ratio of Short-Term Indebtedness to Capital|TECX (Tectonic Therapeutic Inc.) - Short-Term Debt to Capital|Current Liabilities to Capital Tonix Pharmaceuticals Holding TNXP|Short-Term Debt to Equity China SXT Pharmaceuticals (SXTC)|EPRX (eupraxiapharma.com) - Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Equity BioHarvest Sciences Inc. BHST|Invizyne Technologies - Short-Term Debt to Equity|ORMP: Short-Term Debt to Equity Ratio|Current Liabilities to Capital Entera Bio Ltd.|MindWalk Holdings (HYFT) - Short-Term Debt to Equity|abvcpharma.com - Ratio of Short-Term Indebtedness to Capital|CPIX (Cumberland Pharmaceuticals Inc.) - Short-Term Debt to Capital|Short-Term Debt to Capital Quantum BioPharma Ltd.|Short-Term Debt to Equity Ratio FGEN (FibroGen Corp)|TELO (Telomir Pharmaceuticals Corp) - Ratio of Short-Term Indebtedness to Capital|Rani Therapeutics Holdings, Inc. - Short-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio SNYR (Synergy CHC Corp.)|Rallybio Corp. - Short-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital LEXX (Lexaria Bioscience)|PULM: Short-Term Debt to Capital|Current Liabilities to Capital Pheton Holdings (PTHL)|Short-Term Debt to Equity Aptorum Group Ltd|IBO: Ratio of Short-Term Indebtedness to Capital|Short-Term Debt to Capital TNFA|Short-Term Debt to Capital cbdmd.com (YCBD)|Short-Term Debt to Equity PainReform Limited PRFX|CYTO (Altamira Therapeutics Ltd) - Current Liabilities to Equity|Lipella Pharmaceuticals - Short-Term Debt to Capital|Current Liabilities to Capital optinose.com|PIRS (Pieris Pharmaceuticals, Inc.) - Short-Term Debt to Equity Ratio|Procaps Group (PROC) - Short-Term Debt to Capital|Short-Term Debt to Equity Ratio PTPI|QLI (Qilian International Corp) - Short-Term Loans to Capital Ratio|Short-Term Debt to Capital SLRN|Short-Term Debt to Capital Coefficient tffpharma.com